CRIS

   Educational Index      Patient Resources      Print Pamphlet  

 Schizophrenia Facts
      Defined
       Facts
       Treatment
       Resources

Schizophrenia

When Someone Has Schizophrenia
Schizophrenia is a devastating mental illness-the most chronic and disabling of the severe mental disorders. The first signs of schizophrenia, which typically emerge in young people in their teens or twenties, are confusing and often shocking to families and friends. Hallucinations, delusions, disordered thinking; unusual speech or behavior and social withdrawal impair the ability to interact with others. Most people with schizophrenia suffer chronically or episodically throughout their lives, losing opportunities for careers and relationships. They are stigmatized by lack of public understanding about the disease. While newer treatments with fewer side effects have improved the lives of many people with schizophrenia, only one in five recovers.  One in 10 commits suicide.

Return to the top of the page


Some Facts About Schizophrenia 
·         In the United States, more than 2 million people have schizophrenia. 

·         Schizophrenia costs the United States $32.5 billion annually. 

·         Worldwide, rates of schizophrenia are about 1% of the population, very similar from country to country. 

·         People with schizophrenia are far more likely to be victims of violence and crime than to commit violent acts themselves. 

·         People with schizophrenia have an increased risk of violent behavior only when untreated or when engaging in substance abuse. 

·         Many years of family studies indicate that vulnerability to schizophrenia is inherited. However, among individuals with schizophrenia who have an identical twin, and thus share the exact genetic makeup, there is only a 50 percent chance that both twins will be affected with the disease. Scientists conclude that some environmental influence, perhaps occurring during fetal development, accounts for the difference. 

·         Advances in neuroimaging technology have shown that some people with schizophrenia have abnormalities in brain structure consisting of enlarged ventricles, fluid-filled cavities deep within the brain. 

·         Research indicates that schizophrenia may be a developmental disorder resulting from impaired migration of neurons in the brain during fetal development. 

Return to the top of the page


Treatments for Schizophrenia 
A number of new, effective medications for schizophrenia with fewer side effects than older medications have been introduced in the past decade. The newer drugs are very effective in the treatment of psychosis, including hallucinations and delusions, and may also be helpful for treating reduced motivation or blunted emotional expression. 

Because of the nature of the disorder, some people with schizophrenia may deny that they need medications and may either refuse to take them or stop taking them because of undesired side effects. Remembering to take medications may be difficult because of the disorganized thinking characteristic of people with schizophrenia. A major goal of research at NIMH is the discovery of new, effective and safe treatments that can be given in longer-acting doses. 

Present and Future Research Directions  
In addition to the development of new treatments, NIMH research is focusing on the relationships between genetic, behavioral, developmental, social and other factors to identify the cause or causes of schizophrenia. Utilizing increasingly precise imaging techniques, scientists are studying the structure and function of the living brain. New molecular tools and modern statistical analyses are enabling researchers to close in on the particular genes that affect brain development or brain circuitry involved in schizophrenia. Scientists are continuing to investigate possible prenatal factors, including infections, which may affect brain development and contribute to the development of schizophrenia.

This information is available courtesy of the NIMH.  It is in the public domain and can be downloaded, reproduced, or copied without permission. For more information go to http://www.nimh.nih.gov/practitioners/patinfo.cfm

 

Return to the top of the page


Resources
Information, support, and advocacy organizations: 
The National Alliance for the Mentally Ill (NAMI)
200 North Glebe Road, Suite 1015
Arlington, VA 22203-3754
Phone: 1-800-950-NAMI (6264) or (703) 524-7600
Internet: http://www.nami.org 

National Mental Health Association (NMHA)
1021 Prince Street
Alexandria, VA 22314-2971
Phone: 1-800-969-6942 or (703) 684-7722
Internet: http://www.nmha.org

National Mental Health Consumers' Self-Help Clearinghouse
1211 Chestnut Street, Suite 1000 
Philadelphia, PA 19107 
Phone: 1-800-553-4key (4539) or (215) 751-1810
Internet: http://www.mhselfhelp.org/index2.html 

National Alliance for Research on Schizophrenia and Depression (NARSAD)
60 Cutter Mill Road, Suite 404
Great Neck, NY 11021
Phone: (516) 829-0091
Internet: http://www.mhsource.com

Information on research into the brain, behavior, and mental disorders contact:
National Institute of Mental Health (NIMH)
Office of Communication and Public Liaison
Information Resources and Inquiries Branch
6001 Executive Boulevard, Rm. 8184, MSC 9663
Bethesda, MD 20892-9663
Phone: 301-443-4513

This information is available courtesy of the NIMH.  It is in the public domain and can be downloaded, reproduced, or copied without permission. For more information go to http://www.nimh.nih.gov/practitioners/patinfo.cfm

Return to the top of the page